NCT00106015 Diamond Blackfan Anemia Registry (DBAR)
| NCT ID | NCT00106015 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwell Health |
| Condition | Anemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2004-09 |
| Primary Completion | 2030-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2004-09 with a primary completion date of 2030-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to maintain a comprehensive registry of patients with the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA).
Eligibility Criteria
Inclusion Criteria: * Patients must meet the diagnostic criteria for DBA which include the following: 1. Normochromic, usually macrocytic and occasionally normocytic anemia developing early in childhood 2. Reticulocytopenia 3. Normocellular bone marrow with a selective deficiency of red cell precursors 4. Normal or slightly decreased leukocyte count 5. Normal or often increased platelet count 6. Or, a confirmed mutation in one of the identified DBA genes Exclusion Criteria: * Any subject identified as having another bone marrow failure syndrome (eg. Fanconi anemia, dyskeratosis congenita, Shwachman Diamond syndrome, etc.) will be excluded.
Contact & Investigator
Adrianna Vlachos, MD
PRINCIPAL INVESTIGATOR
Cohen Children's Medical Center of NY/Feinstein Institutute for Medical Research
Frequently Asked Questions
Who can join the NCT00106015 clinical trial?
This trial is open to participants of all sexes, studying Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00106015 currently recruiting?
Yes, NCT00106015 is actively recruiting participants. Contact the research team at eatsidaf@northwell.edu for enrollment information.
Where is the NCT00106015 trial being conducted?
This trial is being conducted at New Hyde Park, United States.
Who is sponsoring the NCT00106015 clinical trial?
NCT00106015 is sponsored by Northwell Health. The principal investigator is Adrianna Vlachos, MD at Cohen Children's Medical Center of NY/Feinstein Institutute for Medical Research. The trial plans to enroll 900 participants.